# Croma-Pharma GmbH: PMA supplement approved for saypha® ChiQ™

**Score:** 60/100

| Field | Value |
|---|---|
| Sponsor | Croma-Pharma GmbH |
| Product | saypha® ChiQ™ |
| Generic / ingredient | Implant, dermal, for aesthetic use |
| Approval | PMA supplement (device change) |
| Application | P250021 S001 |
| Decided | 2026-10-07 |
| Panel / class | General, Plastic Surgery |
| Sponsor location | Leobendorf |

## Why this score
- Decided in the last 30 days.

Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration) (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P250021S001). Last refreshed: 2026-11-04T06:06:18.796Z.
From openFDA (PMA and Drugs@FDA). openFDA can lag FDA decisions by days to weeks. Drug supplement types follow the FDA submission class (labeling and REMS, manufacturing/CMC, efficacy, other). Company and product level only. Verify on FDA databases before relying on an approval.